Page 120 - Read Online

Page 298 Nociti. Neuroimmunol Neuroinflammation 2020;7:291-9 I http://dx.doi.org/10.20517/2347-8659.2020.25

16. Dendrou CA, Fugger L, Friese MA. Immunopathology of multiple sclerosis. Nat Rev Immunol 2015;15:545-58.
17. Kaskow BJ, Baecher-Allan C. Effector T cells in multiple sclerosis. Cold Spring Harb Perspect Med 2018;8:a029025.
18. Kitz A, Singer E, Hafler D. Regulatory T cells: from discovery to autoimmunity. Cold Spring Harb Perspect Med 2018;8:a029041.
19. Viglietta V, Baecher-Allan C, Weiner HL, Hafler DA. Loss of functional suppression by CD4+ CD25+ regulatory T cells in patients with
multiple sclerosis. J Exp Med 2004;199:971-9.
20. Venken K, Hellings N, Thewissen M, Somers V, Hensen K, et al. Compromised CD4+ CD25(high) regulatory T-cell function in patients
with relapsing-remitting multiple sclerosis is correlated with a reduced frequency of FOXP3-positive cells and reduced FOXP3 expression
at the single-cell level. Immunology 2008;123:79-89.
21. Frisullo G, Nociti V, Iorio R, Patanella AK, Caggiula M, et al. Regulatory T cells fail to suppress CD4T+-bet+ T cells in relapsing
multiple sclerosis patients. Immunology 2009;127:418-28.
22. Filippi M, Bar-Or A, Piehl F, Preziosa P, Solari A, et al. Multiple sclerosis. Nat Rev Dis Primers 2018;4:43.
23. Magliozzi R, Howell O, Vora A, Serafini B, Nicholas R, et al. Meningeal B-cell follicles in secondary progressive multiple sclerosis
associate with early onset of disease and severe cortical pathology. Brain 2007;130:1089-104.
24. Aloisi F, Pujol-Borrell R. Lymphoid neogenesis in chronic inflammatory diseases. Nat Rev Immunol 2006;6:205-17.
25. Serafini B, Rosicarelli B, Magliozzi R, Stigliano E, Aloisi F. Detection of ectopic B-cell follicles with germinal centers in the meninges of
patients with secondary progressive multiple sclerosis. Brain Pathol 2004;14:164-74.
26. Correale J, Gaitán MI, Ysrraelit MC, Fiol MP. Progressive multiple sclerosis: from pathogenic mechanisms to treatment. Brain
2017;140:527-46.
27. Correale J. The role of microglial activation in disease progression. Mult Scler 2014;20:1288-95.
28. Kutzelnigg A, Lucchinetti CF, Stadelmann C, Brück W, Rauschka H, et al. Cortical demyelination and diffuse white matter injury in
multiple sclerosis. Brain 2005;128:2705-12.
29. Nikić I, Merkler D, Sorbara C, Brinkoetter M, Kreutzfeldt M, et al. A reversible form of axon damage in experimental autoimmune
encephalomyelitis and multiple sclerosis. Nat Med 2011;17:495-9.
30. Correale J, Farez MF. The Role of Astrocytes in Multiple Sclerosis Progression. Front Neurol 2015;6:180.
31. Butovsky O, Ziv Y, Schwartz A, Landa G, Talpalar AE, et al. Microglia activated by IL-4 or IFN-gamma differentially induce
neurogenesis and oligodendrogenesis from adult stem/progenitor cells. Mol Cell Neurosci 2006;31:149-60.
32. Arnett HA, Mason J, Marino M, Suzuki K, Matsushima GK, et al. TNF alpha promotes proliferation of oligodendrocyte progenitors and
remyelination. Nat Neurosci 2001;4:1116-22.
33. Arnett HA, Wang Y, Matsushima GK, Suzuki K, Ting JP. Functional genomic analysis of remyelination reveals importance of
inflammation in oligodendrocyte regeneration. J Neurosci 2003;23:9824-32.
34. Torcia M1, Bracci-Laudiero L, Lucibello M, Nencioni L, Labardi D, et al. Nerve growth factor is an autocrine survival factor for memory
B lymphocytes. Cell 1996;85:345-56.
35. Ehrhard PB, Erb P, Graumann U, Otten U. Expression of nerve growth factor and nerve growth factor receptor tyrosine kinase Trk in
activated CD4-positive T-cell clones. Proc Natl Acad Sci U S A 1993;90:10984-8.
36. Aarum J, Sandberg K, Haeberlein SL, Persson MA. Migration and differentiation of neural precursor cells can be directed by microglia.
Proc Natl Acad Sci U S A 2003;100:15983-8.
37. Lombardi M, Parolisi R, Scaroni F, Bonfanti E, Gualerzi A, et al. Detrimental and protective action of microglial extracellular vesicles on
myelin lesions: astrocyte involvement in remyelination failure. Acta Neuropathol 2019;138:987-1012.
38. Kotter MR, Setzu A, Sim FJ, Van Rooijen N, Franklin RJ. Macrophage depletion impairs oligodendrocyte remyelination following
lysolecithin-induced demyelination. Glia 2001;35:204-12.
39. Liu Y, Teige I, Birnir B, Issazadeh-Navikas S. Neuron-mediated generation of regulatory T cells from encephalitogenic T cells suppresses
EAE. Nat Med 2006;12:518-25.
40. Griffiths M1, Neal JW, Gasque P. Innate immunity and protective neuroinflammation: new emphasis on the role of neuroimmune
regulatory proteins. Int Rev Neurobiol 2007;82:29-55.
41. Pender MP1, Rist MJ. Apoptosis of inflammatory cells in immune control of the nervous system: role of glia. Glia 2001;36:137-44.
42. Aloisi F, Penna G, Cerase J, Menéndez Iglesias B, Adorini L. IL-12 production by central nervous system microglia is inhibited by
astrocytes. J Immunol 1997;159:1604-12.
43. Lewin GR, Barde YA. Physiology of the neurotrophins. Annu Rev Neurosci 1996;19:289-317.
44. Poo MM. Neurotrophins as synaptic modulators. Nat Rev Neurosci 2001;2:24-32.
45. Blesch A. Neurotrophic factors in neurodegeneration. Brain Pathol 2006;16:295-303.
46. Hu Y, Russek SJ. BDNF and the diseased nervous system: a delicate balance between adaptive and pathological processes of gene
regulation. J Neurochem 2008;105:1-17.
47. Asami T, Ito T, Fukumitsu H, Nomoto H, Furukawa Y, et al. Autocrine activation of cultured macrophages by brain-derived neurotrophic
factor. Biochem Biophys Res Commun 2006;344:941-7.
48. Mizoguchi Y, Monji A, Kato T, Seki Y, Gotoh L, et al. Brain-derived neurotrophic factor induces sustained elevation of intracellular Ca
2+
in rodent microglia. J Immunol 2009;183:7778-86.
49. Aid T, Kazantseva A, Piirsoo M, Palm K, Timmusk T. Mouse and rat BDNF gene structure and expression revisited. J Neurosci Res
2007;85:525-35.
50. Pruunsild P, Kazantseva A, Aid T, Palm K, Timmusk T. Dissecting the human BDNF locus: bidirectional transcription, complex splicing,
and multiple promoters. Genomics 2007;90:397-406.